Attention-Deficit Hyperactivity Disorder (ADHD)

  • 3 Hallmark symptoms:

    • inattention

    • hyperactivity

    • impulsivity

  • Age of onset is usually before 12

  • Risk of comorbid psychiatric disorders with ADHD

  • Symptoms of ADHD must persist for at least 6 months to be considered diagnostic

  • Screen via the following for cardiovascular risk factors before initiating stimulants:

    • blood pressure, heart rate, height/weight, re-assess at f/u

    • only ECG in patients with concurrent cardiac abnormalities or those with a family hx of cardiac disease or sudden death

Therapy

Nonpharmacological

  • parent/teacher training first-line in pre-school aged children

  • Options include:

    • behaviour management, CBT, parent training, organizational skill training, etc.

  • less effective than stimulants, but combined nonpharm/pharm therapy observed to be more effective than either alone

  • Exercise also found to improve core ADHD symptoms, reduce anxiety, and improve cognitive function

  • insufficient data exists to say whether specific diets affed ADHD signs/symptoms

Pharmacological

  • methylphenidate only considered in preschoolers if they have moderate to severe ADHD and do not respond to behavioural therapy. This is along as the benefit outweighs the harm

Stimulants

  • long-acting stimulants considered first-line

  • Efficacy and safety differences between stimulants are minimal

  • Limited evidence shows preference for amphetamines as first line for adults, and methylphenidate for children

  • Immediate- and intermediate-acting stimulants are recommended for use when the patient requires more flexible dosing and minimal hours/day of medication or as add-on therapy to an extended-release formulation.

  • Benefit is typically seen in the first week of therapy-

  • A full trial is 3-4 weeks for stimulants, with a continuation for 6-12 months if response is adequate with little to no adverse effects

  • Stimulant contraindications:

    • history of hypersensitivity to sympathomimetic amines

    • symptomatic CVD

    • uncontrolled hyperthyroidism

    • Hx of drug abuse

    • concurrent use with an MAOI

  • What CNS stimulant is not typically used in ADHD due to reduced efficacy?

    • Modafinil

Long-Acting Stimulants

Drugs

Duration of Action

Safety

Interactions

Notes

Lisdexamphetamine (Vyvanse)

13 to 14 hours

Methylphenidate CR (Biphentin)

10-12 hours

Mixed salts amphetamine (Adderall XR)

10-12 hrs

Intermediate-Acting Stimulants

Drugs

Duration of Action

Safety

Interactions

Notes

Methylphenidate SR (Ritalin)

3-8 hrs

Dextroamphetamine SR (Dexedrine)

6-8 hrs

Immediate-Acting Stimulants

Drugs

Duration of Action

Safety

Interactions

Notes

Dextroamphetamine IR

3-5 hrs

Common:
insomnia, loss of appetite, irritable, dizzy, stomach pain
Rare (call MD)
zombie-like, psychotic reactions, agitation, tachycardia, hypertension, growth failure, rebound hyperactivity

  • avoid MAOIs (incr hypertensive effect)

Stimulant OD symptoms: glassy eyes, insomnia, hyperactivity